In this week’s video, Dr. Brian Durie discusses why the ideal therapy for high-risk myeloma is still unknown, but presents options for treatment.

BOTTOM LINE:
Because of the different types of high-risk myeloma, discuss various treatment options with your doctor.

Have a question? Submit it to AskDrDurie@myeloma.org

IMF Chairman and Co-Founder Brian G.M. Durie, MD welcomes your questions about the latest myeloma treatments, research, controversies and quality of life issues. If you have a question you think might be of interest to the myeloma community, please send to askdrdurie@myeloma.org!

For questions of a specific personal nature, please call the IMF InfoLine coordinators at 800.452.2873 or email them at infoline@myeloma.org

Previous Post
If my myeloma is in remission and my IgG myeloma protein has spiked, why is my doctor not recommending any new treatment?
Next Post
If I have a sustained remission and am on Revlimid, should I continue using it?

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.